AVEO Oncology

Aveo Oncology

Biotechnology, 30 Winter St, Boston, Massachusetts, 02108, United States, 51-200 Employees

aveooncology.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is AVEO ONCOLOGY

AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVD...

Read More

map
  • 30 Winter St, Boston, Massachusetts, 02108, United States Headquarters: 30 Winter St, Boston, Massachusetts, 02108, United States
  • 2001 Date Founded: 2001
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $50 Million to $100 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2834 | NAICS Code: 541711 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from AVEO ONCOLOGY

AVEO Oncology Org Chart and Mapping

Employees

Robert Guillemette

Senior Manager Regulatory Affairs

Ken Kirsch

Director, Market Insights

Melissa Gilliam

Oncology Account Manager

Alex Le

Medical Science Liaison

Matt Coulter

Vice President Information Technology

Kevin Reid

Oncology Account Manager

Greg Rink

Oncology Account Manager

David Crist

Vice President of Sales Oncology Hematology

Manoj Patel

Vice President Program Management

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding AVEO Oncology

Answer: AVEO Oncology's headquarters are located at 30 Winter St, Boston, Massachusetts, 02108, United States

Answer: AVEO Oncology's phone number is 85********

Answer: AVEO Oncology's official website is https://aveooncology.com

Answer: AVEO Oncology's revenue is $50 Million to $100 Million

Answer: AVEO Oncology's SIC: 2834

Answer: AVEO Oncology's NAICS: 541711

Answer: AVEO Oncology has 51-200 employees

Answer: AVEO Oncology is in Biotechnology

Answer: AVEO Oncology contact info: Phone number: 85******** Website: https://aveooncology.com

Answer: AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA (tivozanib) in the U.S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in RCC and other indications, and has other investigational programs in clinical development. AVEO is committed to creating an environment of diversity, equity and inclusion to diversify representation within the Company.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access